
Biographie pas encore disponible.
Événements
11
Avr
2025
Conférence
M. MANTEGAZZA invite le Dr. Jan DOLZER
« What is Hidden under the Noise in Electrophysiological Experiments ? – Tips, Tricks and Strategies Using a Pragmatic Approach »
IPMC
30
Juin
2025
11:00 am
Conférence
Massimo MANTEGAZZA invite le Dr. Dirk ISBRANDT
« Early postnatal CA3 hyperexcitability drives hippocampal development and epiletogenesis in SCN2A development and epilectic encephalopathy«
IPMC
02
Juin
2025
2:00 pm
Conférence
Massimo MANTEGAZZA invite le Pr. Amy LEE
« Caldendrin : a multi-functional regulator of sensory ion channels »
IPMC
01
Juil
2025
2:30 pm
Thèse
Thèse de Martina SIMONTI
« Phénotype autistique et mécanismes physiopathologiques chez des souris modélisant des mutations humaines du gène SCN2A« Directeur de thèse : Massimo […]
IPMC
Publications
2025
GABAergic neurons can facilitate the propagation of cortical spreading depolarization: experiments in mouse neocortical slices and a novel neural field computational model,
PLoS Comput Biol . 2025 Jun 4;21(6):e1013099.
2025
Neurodevelopmental defects in Dravet syndrome Scn1a+/− mice: Targeting GABA-switch rescues behavioral dysfunctions but not seizures and mortality,
Neurobiol Dis. 2025 Apr;207:106853.
2025
The role of electroencephalography in epilepsy research-From seizures to interictal activity and comorbidities,
Epilepsia . 2025 May;66(5):1374-1393. .
2024
Voltage-gated sodium channels in genetic epilepsy: up and down of excitability.,
J Neurochem 2024 Dec; 168(12): 3872-3890.
2024
Preictal dysfunctions of inhibitory interneurons paradoxically lead to their rebound hyperactivity and to low-voltage-fast onset seizures in Dravet syndrome.,
Proc Natl Acad Sci U S A 2024 Jun; 121(23): e2316364121.
2024
Brainstem depolarization-induced lethal apnea associated with gain-of-function SCN1AL263V is prevented by sodium channel blockade.,
Proc Natl Acad Sci U S A 2024 Apr; 121(14): e2309000121.
2024
WONOEP appraisal: Targeted therapy development for early onset epilepsies.,
Epilepsia 2024 Nov; (): .
2024
Are we there yet? A critical evaluation of sudden and unexpected death in epilepsy models.,
Epilepsia 2024 Jan; 65(1): 9-25.
2023
Structure-function relationship of new peptides activating human Nav1.1.,
Biomed Pharmacother 2023 Sep; 165(): 115173.
2023
Idealized multiple-timescale model of cortical spreading depolarization initiation and pre-epileptic hyperexcitability caused by NaV1.1/SCN1A mutations.,
J Math Biol 2023 May; 86(6): 92.
2023
Gain of function SCN1A disease-causing variants: Expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication.,
Epilepsia 2023 May; 64(5): 1331-1347.
2023
Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum.,
Physiol Rev 2023 Jan; 103(1): 433-513.
2023
Involvement of GABAergic Interneuron Subtypes in 4-Aminopyridine-Induced Seizure-Like Events in Mouse Entorhinal Cortex in Vitro.,
J Neurosci 2023 Mar; 43(11): 1987-2001.
2022
Predictive precision medicine efforts for voltage-gated sodium channel genetic variants.,
Brain 2022 Dec; 145(12): 4148-4150.
2022
The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications.,
Brain 2022 Nov; 145(11): 3816-3831.
2022
A companion to the preclinical common data elements for rodent genetic epilepsy models. A report of the TASK3-WG1B: Paediatric and genetic models working group of the ILAE/AES joint translational TASK force.,
Epilepsia Open 2022 Aug; (): .
2022
Rescuing epileptic and behavioral alterations in a Dravet syndrome mouse model by inhibiting eukaryotic elongation factor 2 kinase (eEF2K).,
Mol Autism 2022 Jan; 13(1): 1.
2021
Initiation of migraine-related cortical spreading depolarization by hyperactivity of GABAergic neurons and NaV1.1 channels.,
J Clin Invest 2021 Nov; 131(21): .
2021
Sodium channelopathies of skeletal muscle and brain.,
Physiol Rev 2021 Oct; 101(4): 1633-1689.
2021
Modeling NaV1.1/SCN1A sodium channel mutations in a microcircuit with realistic ion concentration dynamics suggests differential GABAergic mechanisms leading to hyperexcitability in epilepsy and hemiplegic migraine.,
PLoS Comput Biol 2021 Jul; 17(7): e1009239.
2021
Histone Deacetylase Inhibitors Ameliorate Morphological Defects and Hypoexcitability of iPSC-Neurons from Rubinstein-Taybi Patients.,
Int J Mol Sci 2021 May; 22(11): .
2021
Fluorescent- and tagged-protoxin II peptides: potent markers of the Nav 1.7 channel pain target.,
Br J Pharmacol 2021 Jul; 178(13): 2632-2650.
2020
SULT4A1 Modulates Synaptic Development and Function by Promoting the Formation of PSD-95/NMDAR Complex.,
J Neurosci 2020 Sep; 40(37): 7013-7026.
2020
Cholinergic modulation inhibits cortical spreading depression in mouse neocortex through activation of muscarinic receptors and decreased excitatory/inhibitory drive.,
Neuropharmacology 2020 Apr; 166(): 107951.
2019
SCN1A/NaV 1.1 channelopathies: Mechanisms in expression systems, animal models, and human iPSC models.,
Epilepsia 2019 Dec; 60 Suppl 3(): S25-S38.
2019
NaV1.2 haploinsufficiency in Scn2a knock-out mice causes an autistic-like phenotype attenuated with age.,
Sci Rep 2019 Sep; 9(1): 12886.
2019
Hyperexcitability in Cultured Cortical Neuron Networks from the G93A-SOD1 Amyotrophic Lateral Sclerosis Model Mouse and its Molecular Correlates.,
Neuroscience 2019 Sep; 416(): 88-99.
2019
A two-hit story: Seizures and genetic mutation interaction sets phenotype severity in SCN1A epilepsies.,
Neurobiol Dis 2019 May; 125(): 31-44.
2018
Rare coding variants in genes encoding GABAA receptors in genetic generalised epilepsies: an exome-based case-control study.,
Lancet Neurol 2018 Aug; 17(8): 699-708.
2018
New Insights Into the Role of Cav2 Protein Family in Calcium Flux Deregulation in Fmr1-KO Neurons.,
Front Mol Neurosci 2018 ; 11(): 342.
2017
The X-Linked Intellectual Disability Protein IL1RAPL1 Regulates Dendrite Complexity.,
J Neurosci 2017 Jul; 37(28): 6606-6627.
2017
Network topology of NaV1.7 mutations in sodium channel-related painful disorders.,
BMC Syst Biol 2017 Feb; 11(1): 28.
2017
Depletion of the Fragile X Mental Retardation Protein in Embryonic Stem Cells Alters the Kinetics of Neurogenesis.,
Stem Cells 2017 Feb; 35(2): 374-385.
2014
Genetic epilepsy syndromes without structural brain abnormalities: clinical features and experimental models.,
Neurotherapeutics 2014 Apr; 11(2): 269-85.
2013
Nonfunctional NaV1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects.,
Proc Natl Acad Sci U S A 2013 Oct; 110(43): 17546-51.
2013
Loss-of-function KCNH2 mutation in a family with long QT syndrome, epilepsy, and sudden death.,
Epilepsia 2013 Aug; 54(8): e112-6.
2013
Hippocampal hyperexcitability and specific epileptiform activity in a mouse model of Dravet syndrome.,
Epilepsia 2013 Jul; 54(7): 1251-61.
2013
Divergent effects of the T1174S SCN1A mutation associated with seizures and hemiplegic migraine.,
Epilepsia 2013 May; 54(5): 927-35.
2013
Comparative neuronal differentiation of self-renewing neural progenitor cell lines obtained from human induced pluripotent stem cells.,
Front Cell Neurosci 2013 ; 7(): 175.
2013
Phenytoin inhibits the persistent sodium current in neocortical neurons by modifying its inactivation properties.,
PLoS One 2013 ; 8(1): e55329.
2012
The 22nd ion channel meeting, september 2011, france.,
Channels (Austin) 2012 ; 6(3): 149-53.
2012
Pure haploinsufficiency for Dravet syndrome Na(V)1.1 (SCN1A) sodium channel truncating mutations.,
Epilepsia 2012 Jan; 53(1): 87-100.
2010
Na+ channelopathies and epilepsy: recent advances and new perspectives.,
Expert Rev Clin Pharmacol 2010 May; 3(3): 371-84.
2010
Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders.,
Lancet Neurol 2010 Apr; 9(4): 413-24.
2009
Progressive neurocognitive decline in two children with Dravet syndrome, de novo SCN1A truncations and different epileptic phenotypes.,
Am J Med Genet A 2009 Oct; 149A(10): 2339-45.
2009
A BAC transgenic mouse model reveals neuron subtype-specific effects of a Generalized Epilepsy with Febrile Seizures Plus (GEFS+) mutation.,
Neurobiol Dis 2009 Jul; 35(1): 91-102.
2009
A rescuable folding defective Nav1.1 (SCN1A) sodium channel mutant causes GEFS+: common mechanism in Nav1.1 related epilepsies?,
Hum Mutat 2009 Jul; 30(7): E747-60.
2008
Self-limited hyperexcitability: functional effect of a familial hemiplegic migraine mutation of the Nav1.1 (SCN1A) Na+ channel.,
J Neurosci 2008 Jul; 28(29): 7273-83.
2007
Modulatory proteins can rescue a trafficking defective epileptogenic Nav1.1 Na+ channel mutant.,
J Neurosci 2007 Oct; 27(41): 11037-46.
2007
Electroclinical features of a family with simple febrile seizures and temporal lobe epilepsy associated with SCN1A loss-of-function mutation.,
Epilepsia 2007 Sep; 48(9): 1691-1696.
2007
Epileptogenic channelopathies: experimental models of human pathologies.,
Epilepsia 2007 ; 48 Suppl 2(): 51-64.
2006
Effects in neocortical neurons of mutations of the Na(v)1.2 Na+ channel causing benign familial neonatal-infantile seizures.,
J Neurosci 2006 Oct; 26(40): 10100-9.
2006
Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy.,
Nat Neurosci 2006 Sep; 9(9): 1142-9.
2005
Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures.,
Proc Natl Acad Sci U S A 2005 Dec; 102(50): 18177-82.
2005
Beta-scorpion toxin effects suggest electrostatic interactions in domain II of voltage-dependent sodium channels.,
J Physiol 2005 Oct; 568(Pt 1): 13-30.
2005
A new type of scorpion Na+-channel-toxin-like polypeptide active on K+ channels.,
Biochem J 2005 Jun; 388(Pt 2): 455-64.
2005
Molecular determinants for modulation of persistent sodium current by G-protein betagamma subunits.,
J Neurosci 2005 Mar; 25(13): 3341-9.
2004
First chemical synthesis of a scorpion alpha-toxin affecting sodium channels: the Aah I toxin of Androctonus australis hector.,
J Pept Sci 2004 Nov; 10(11): 666-77.
2004
Protein-kinase C-dependent phosphorylation inhibits the effect of the antiepileptic drug topiramate on the persistent fraction of sodium currents.,
Neuroscience 2004 ; 127(1): 63-8.
2001
Role of the C-terminal domain in inactivation of brain and cardiac sodium channels.,
Proc Natl Acad Sci U S A 2001 Dec; 98(26): 15348-53.
2001
Neutralization of gating charges in domain II of the sodium channel alpha subunit enhances voltage-sensor trapping by a beta-scorpion toxin.,
J Gen Physiol 2001 Sep; 118(3): 291-302.
1999
Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate.,
J Pharmacol Exp Ther 1999 Mar; 288(3): 960-8.
1998
Valproate selectively reduces the persistent fraction of Na+ current in neocortical neurons.,
Epilepsy Res 1998 Sep; 32(1-2): 304-8.
1998
Anemone toxin (ATX II)-induced increase in persistent sodium current: effects on the firing properties of rat neocortical pyramidal neurones.,
J Physiol 1998 Feb; 507 ( Pt 1)(Pt 1): 105-16.
1998
Modalities of distortion of physiological voltage signals by patch-clamp amplifiers: a modeling study.,
Biophys J 1998 Feb; 74(2 Pt 1): 831-42.
1996
Action potentials recorded with patch-clamp amplifiers: are they genuine?,
Trends Neurosci 1996 Dec; 19(12): 530-4.
1995
Stimulation of single L-type calcium channels in rat pituitary GH3 cells by thyrotropin-releasing hormone.,
EMBO J 1995 Mar; 14(6): 1075-83.
1994
Muscarinic regulation of Ca2+ currents in rat sensory neurons: channel and receptor types, dose-response relationships and cross-talk pathways.,
Eur J Neurosci 1994 Mar; 6(3): 381-91.